Pharma Valid Machines Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 732.17%
- Profit Growth 332.10%
- Ebitda 455.63%
- Net Worth 119.31%
- Total Assets -45.82%
About Pharma Valid Machines
Pharma Valid Machines Private Limited (PVMPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 January 2020 (Five years and one month 20 days old ). Its registered office is in Navi Mumbai, Maharashtra.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Girish Panchal, Beena Mane, and Suryakant Mane serve as directors at the Company.
Company Details
- Location Navi Mumbai, Maharashtra
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U29308MH2020PTC335510
- Company No.
335510
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jan 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Pharma Valid Machines?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suryakant Mane  | Managing Director | 06-Jan-2020 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Girish Panchal | Director | 04-Jun-2021 | Current |
| Beena Mane | Director | 06-Jan-2020 | Current |
Financial Performance of Pharma Valid Machines.
Pharma Valid Machines Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 732.17% increase. The company also saw a substantial improvement in profitability, with a 332.1% increase in profit. The company's net worth Soared by an impressive increase of 119.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharma Valid Machines?
Unlock access to Pharma Valid Machines's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharma Valid Machines?
Unlock and access historical data on people associated with Pharma Valid Machines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharma Valid Machines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharma Valid Machines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.